195990 — ABPro Bio Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩146bn
- KR₩139bn
- KR₩25bn
Annual cashflow statement for ABPro Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -39,290 | -61,617 | -10,515 | -8,145 | -25,742 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 14,432 | 50,842 | 4,950 | -451 | 16,893 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 22,765 | 6,005 | 721 | -5,267 | 2,117 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2,369 | 2,479 | -2,220 | -12,461 | -4,862 |
| Capital Expenditures | -2,938 | -654 | -3,787 | -2,350 | -2,239 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -94,691 | 248 | 12,135 | -19,002 | 7,872 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -97,629 | -406 | 8,348 | -21,352 | 5,633 |
| Financing Cash Flow Items | 1,681 | 28.5 | -5.47 | -38.9 | 13,019 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 103,389 | 9,334 | 20,303 | -3,373 | 1,178 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7,927 | 11,883 | 27,120 | -37,009 | 1,905 |